Temporomandibular Disorder Pain and Somatic Symptoms in Migraine Patients: Idioms of Psychological Distress and Impact on Quality of Life
Abstract
BACKGROUND: Studies on painful temporomandibular disorders (TMDs) and somatic symptoms in Southeast Asian migraine patients are lacking.
OBJECTIVES: This study investigated the prevalence of TMD pain and somatic symptoms in migraine patients, examining their relationships with pain characteristics, psychological distress, and quality of life (QOL). Additionally, it identified factors associated with moderate-to-severe distress, low QOL, and poor general health.
METHODS: Participants were recruited from a neurology clinic, where migraines were diagnosed based on the ICHD-3 criteria. A trained interviewer administered a questionnaire comprising sociodemographics, migraine-specific information, the DC/TMD TMD pain screener (TPS), Graded Chronic Pain Scale (GCPS), Patient Health Questionnaires (PHQ-15/PHQ-4), and WHOQOL-BREF. Data were analysed employing Chi-square/Mann-Whitney U tests, Spearman's correlation, and logistic regression analysis (α = 0.05).
RESULTS: Among the 106 participants (mean age 45.3 years [SD = 14.0]), 31.1% experienced TMD pain, while 37.7% exhibited medium-to-high somatic symptoms. Individuals with comorbid migraine-TMD pain had a higher somatic symptom burden, distress, and poorer psychological/environmental QOL. Those with medium-to-high somatic symptoms reported more frequent migraines, greater pain intensity/disability, higher TMD pain propensity, elevated distress, and worse QOL in all domains. Somatic symptoms, but not TMD pain, were negatively and…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 106 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.